-
Cangrelor, sold
under the
brand name
Kengreal among others, is a P2Y12
inhibitor FDA
approved as of June 2015 as an
antiplatelet drug for intravenous...
- receptor. On the
other hand,
novel drugs like
ticagrelor (Brilinta®) and
cangrelor (Kengrexal®) are non-thienopyridines and
reversibly inhibit P2Y12 meaning...
-
antiplatelet drugs include:
Adenosine diphosphate (ADP)
receptor inhibitors Cangrelor (Kengreal)
Clopidogrel (Plavix)
Prasugrel (Effient)
Ticagrelor (Brilinta)...
- AR-C 66096 AR-C 67085MX AR-C 69931MX AR-C 118925XX ATP
BzATP C1330-7
Cangrelor Clopidogrel Elinogrel Ip5I MRS-2179 MRS-2211 MRS-2279 MRS-2395 MRS-2500...
- -grel- or -grel for
platelet aggregation inhibitors (e.g. anagrelide,
cangrelor, clopidogrel) -mab for
monoclonal antibodies (e.g. infliximab); see Nomenclature...
-
Treprostinil B01AC22
Prasugrel B01AC23
Cilostazol B01AC24
Ticagrelor B01AC25
Cangrelor B01AC26
Vorapaxar B01AC27
Selexipag B01AC28
Limaprost B01AC30 Combinations...
-
clopidogrel (Plavix),
prasugrel (Efient, Effient),
ticagrelor (Brilinta), and
cangrelor (Kengreal) bind to this
receptor and are
marketed as
antiplatelet agents...
- AR-C 66096 AR-C 67085MX AR-C 69931MX AR-C 118925XX ATP
BzATP C1330-7
Cangrelor Clopidogrel Elinogrel Ip5I MRS-2179 MRS-2211 MRS-2279 MRS-2395 MRS-2500...
-
antiplatelet drugs to
prevent the
formation of
blood clots,
ticagrelor and
cangrelor.
Resistance can
develop quickly with as
little as one mutation. Mutations...
- AR-C 66096 AR-C 67085MX AR-C 69931MX AR-C 118925XX ATP
BzATP C1330-7
Cangrelor Clopidogrel Elinogrel Ip5I MRS-2179 MRS-2211 MRS-2279 MRS-2395 MRS-2500...
